Immunoglobulin-like transcript 3 is expressed by myeloid-derived suppressor cells and correlates with survival in patients with non-small cell lung cancer

References

• Bremnes RM, Al-Shibli K, Donnem T, Sirera R, Al-Saad S, Andersen S, Stenvold H, Camps C, Busund LT. The role of tumor-infiltrating immune cells and chronic inflammation at the tumor site on cancer development, progression, and prognosis: emphasis on non-small cell lung cancer. J Thorac Oncol 2011; 6:824-33; PMID:21173711; http://dx.doi.org/10.1097/JTO.0b013e3182037b76
   PubMed Web of Science ®Google Scholar
• Heuvers ME, Aerts JG, Cornelissen R, Groen H, Hoogsteden HC, Hegmans JP. Patient-tailored modulation of the immune system may revolutionize future lung cancer treatment. BMC Cancer 2012; 12:580; PMID:23217146; http://dx.doi.org/10.1186/1471-2407-12-580
   PubMed Web of Science ®Google Scholar
• Jiang JW, Guo WJ, Liang XH. Phenotypes, accumulation, and functions of myeloid-derived suppressor cells and associated treatment strategies in cancer patients. Human Immunol 2014; 75:1128-37; PMID:25305034; http://dx.doi.org/10.1016/j.humimm.2014.09.025
   PubMed Web of Science ®Google Scholar
• Ortiz ML, Lu L, Ramachandran I, Gabrilovich DI. Myeloid-derived suppressor cells in the development of lung cancer. Cancer Immunol Res 2014; 2:50-8; PMID:24778162; http://dx.doi.org/10.1158/2326-6066.CIR-13-0129
   PubMed Web of Science ®Google Scholar
• Damuzzo V, Pinton L, Desantis G, Solito S, Marigo I, Bronte V, Mandruzzato S. Complexity and challenges in defining myeloid-derived suppressor cells. Cytometry B Clin Cytom 2014; PMID:25504825; http://dx.doi.org/10.1002/cyto.b.21206
   PubMedGoogle Scholar
• Youn JI, Gabrilovich DI. The biology of myeloid-derived suppressor cells: the blessing and the curse of morphological and functional heterogeneity. Eur J Immunol 2010; 40:2969-75; PMID:21061430; http://dx.doi.org/10.1002/eji.201040895
   PubMed Web of Science ®Google Scholar
• Gabrilovich DI, Ostrand-Rosenberg S, Bronte V. Coordinated regulation of myeloid cells by tumours. Nat Rev Immunol 2012; 12:253-68; PMID:22437938; http://dx.doi.org/10.1038/nri3175
   PubMed Web of Science ®Google Scholar
• Filipazzi P, Huber V, Rivoltini L. Phenotype, function and clinical implications of myeloid-derived suppressor cells in cancer patients. Cancer Immunol Immunother 2012; 61:255-63; PMID:22120756; http://dx.doi.org/10.1007/s00262-011-1161-9
   PubMed Web of Science ®Google Scholar
• Buijs N, Luttikhold J, Houdijk APJ, van Leeuwen PAM. The Role of a Disturbed Arginine/NO Metabolism in the Onset of Cancer Cachexia: A Working Hypothesis. Curr Med Chem 2012; 19:5278-86; PMID:22963622; http://dx.doi.org/10.2174/092986712803833290
   PubMed Web of Science ®Google Scholar
• Condamine T, Gabrilovich DI. Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function. Trends Immunol 2011; 32:19-25; PMID:21067974; http://dx.doi.org/10.1016/j.it.2010.10.002
   PubMed Web of Science ®Google Scholar
• Colonna M, Nakajima H, Navarro F, Lopez-Botet M. A novel family of Ig-like receptors for HLA class I molecules that modulate function of lymphoid and myeloid cells. J Leukoc Biol 1999; 66:375-81; PMID:10496306
   PubMed Web of Science ®Google Scholar
• Cheng H, Mohammed F, Nam G, Chen Y, Qi J, Garner LI, Allen RL, Yan J, Willcox BE, Gao GF. Crystal structure of leukocyte Ig-like receptor LILRB4 (ILT3/LIR-5/CD85k): a myeloid inhibitory receptor involved in immune tolerance. J Biol Chem 2011; 286:18013-25; PMID:21454581; http://dx.doi.org/10.1074/jbc.M111.221028
   PubMed Web of Science ®Google Scholar
• Colovai AI, Tsao L, Wang S, Lin H, Wang C, Seki T, Fisher JG, Menes M, Bhagat G, Alobeid B, et al. Expression of inhibitory receptor ILT3 on neoplastic B cells is associated with lymphoid tissue involvement in chronic lymphocytic leukemia. Cytometry B Clin Cytom 2007; 72:354-62; PMID:17266150; http://dx.doi.org/10.1002/cyto.b.20164
   PubMed Web of Science ®Google Scholar
• Orsini G, Legitimo A, Failli A, Ferrari P, Nicolini A, Spisni R, Miccoli P, Consolini R. Quantification of Blood Dendritic Cells in Colorectal Cancer Patients During the Course of Disease. Pathol Oncol Res 2013; 20:267-76; PMID:24022399; http://dx.doi.org/10.1007/s12253-013-9691-4
   PubMedGoogle Scholar
• Leskela S, Rodriguez-Munoz A, de la Fuente H, Figueroa-Vega N, Bonay P, Martin P, Serrano A, Sánchez-Madrid F, González-Amaro R, Marazuela M. Plasmacytoid dendritic cells in patients with autoimmune thyroid disease. J Clin Endocrinol Metab 2013; 98:2822-33; PMID:23666960; http://dx.doi.org/10.1210/jc.2013-1273
   PubMedGoogle Scholar
• Jensen MA, Yanowitch RN, Reder AT, White DM, Arnason BG. Immunoglobulin-like transcript 3, an inhibitor of T cell activation, is reduced on blood monocytes during multiple sclerosis relapses and is induced by interferon beta-1b. Mult Scler 2010; 16:30-8; PMID:20007427; http://dx.doi.org/10.1177/1352458509352794
   PubMedGoogle Scholar
• Suciu-Foca N, Cortesini R. Central role of ILT3 in the T suppressor cell cascade. Cell Immunol 2007; 248:59-67; PMID:17923119; http://dx.doi.org/10.1016/j.cellimm.2007.01.013
   PubMed Web of Science ®Google Scholar
• Kim-Schulze S, Scotto L, Vlad G, Piazza F, Lin H, Liu Z, Cortesini R, Suciu-Foca N. Recombinant Ig-like transcript 3-Fc modulates T cell responses via induction of Th anergy and differentiation of CD8+ T suppressor cells. J Immunol 2006; 176:2790-8; PMID:16493035; http://dx.doi.org/10.4049/jimmunol.176.5.2790
   PubMed Web of Science ®Google Scholar
• Vlad G, Suciu-Foca N. Induction of antigen-specific human T suppressor cells by membrane and soluble ILT3. Exp Mol Pathol 2012; 93:294-301; PMID:23018130; http://dx.doi.org/10.1016/j.yexmp.2012.09.011
   PubMedGoogle Scholar
• Vlad G, Chang CC, Colovai AI, Vasilescu ER, Cortesini R, Suciu-Foca N. Membrane and soluble ILT3 are critical to the generation of T suppressor cells and induction of immunological tolerance. Int Rev Immunol 2010; 29:119-32; PMID:20132030; http://dx.doi.org/10.3109/08830180903281185
   PubMed Web of Science ®Google Scholar
• Cortesini R. Pancreas cancer and the role of soluble immunoglobulin-like transcript 3 (ILT3). JOP 2007; 8:697-703; PMID:17993722
   PubMedGoogle Scholar
• Suciu-Foca N, Feirt N, Zhang QY, Vlad G, Liu Z, Lin H, Chang CC, Ho EK, Colovai AI, Kaufman H, et al. Soluble Ig-like transcript 3 inhibits tumor allograft rejection in humanized SCID mice and T cell responses in cancer patients. J Immunol 2007; 178:7432-41; PMID:17513794; http://dx.doi.org/10.4049/jimmunol.178.11.7432
   PubMed Web of Science ®Google Scholar
• Heuvers ME, Muskens F, Bezemer K, Lambers M, Dingemans AM, Groen HJ, Smit EF, Hoogsteden HC, Hegmans JP, Aerts JG. Arginase-1 mRNA expression correlates with myeloid-derived suppressor cell levels in peripheral blood of NSCLC patients. Lung Cancer 2013; 81:468-74; PMID:23850196; http://dx.doi.org/10.1016/j.lungcan.2013.06.005
   PubMed Web of Science ®Google Scholar
• Rodriguez PC, Ernstoff MS, Hernandez C, Atkins M, Zabaleta J, Sierra R, Ochoa AC. Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes. Cancer Res 2009; 69:1553-60; PMID:19201693; http://dx.doi.org/10.1158/0008-5472.CAN-08-1921
   PubMed Web of Science ®Google Scholar
• Gabitass RF, Annels NE, Stocken DD, Pandha HA, Middleton GW. Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13. Cancer Immunol Immunother 2011; 60:1419-30; PMID:21644036; http://dx.doi.org/10.1007/s00262-011-1028-0
   PubMed Web of Science ®Google Scholar
• Jordan KR, Amaria RN, Ramirez O, Callihan EB, Gao D, Borakove M, Manthey E, Borges VF, McCarter MD. Myeloid-derived suppressor cells are associated with disease progression and decreased overall survival in advanced-stage melanoma patients. Cancer Immunol Immunother 2013; 62:1711-22; PMID:24072401; http://dx.doi.org/10.1007/s00262-013-1475-x
   PubMed Web of Science ®Google Scholar
• Poschke I, Kiessling R. On the armament and appearances of human myeloid-derived suppressor cells. Clin Immunol 2012; 144:250-68; PMID:22858650; http://dx.doi.org/10.1016/j.clim.2012.06.003
   PubMed Web of Science ®Google Scholar
• Chen S, Akbar SM, Abe M, Hiasa Y, Onji M. Immunosuppressive functions of hepatic myeloid-derived suppressor cells of normal mice and in a murine model of chronic hepatitis B virus. Clin Exp Immunol 2011; 166:134-42; PMID:21762128; http://dx.doi.org/10.1111/j.1365-2249.2011.04445.x
   PubMed Web of Science ®Google Scholar
• Ochoa AC, Zea AH, Hernandez C, Rodriguez PC. Arginase, prostaglandins, and myeloid-derived suppressor cells in renal cell carcinoma. Clin Cancer Res 2007; 13:721s-6s; PMID:17255300; http://dx.doi.org/10.1158/1078-0432.CCR-06-2197
   PubMed Web of Science ®Google Scholar
• Liu CY, Wang YM, Wang CL, Feng PH, Ko HW, Liu YH, Wu YC, Chu Y, Chung FT, Kuo CH, et al. Population alterations of L-arginase- and inducible nitric oxide synthase-expressed CD11b+/CD14(−)/CD15+/CD33+ myeloid-derived suppressor cells and CD8+ T lymphocytes in patients with advanced-stage non-small cell lung cancer. J Cancer Res Clin Oncol 2010; 136:35-45; PMID:19572148; http://dx.doi.org/10.1007/s00432-009-0634-0
   PubMed Web of Science ®Google Scholar
• Chang CC, Ciubotariu R, Manavalan JS, Yuan J, Colovai AI, Piazza F, Lederman S, Colonna M, Cortesini R, Dalla-Favera R, et al. Tolerization of dendritic cells by T(S) cells: the crucial role of inhibitory receptors ILT3 and ILT4. Nat Immunol 2002; 3:237-43; PMID:11875462; http://dx.doi.org/10.1038/ni760
   PubMed Web of Science ®Google Scholar
• Ge G, Tian P, Liu H, Zheng J, Fan X, Ding C, Jin Z, Luo X, Xue W. Induction of CD4+ CD25+ Foxp3+ T regulatory cells by dendritic cells derived from ILT3 lentivirus-transduced human CD34+ cells. Transpl Immunol 2012; 26:19-26; PMID:22005288; http://dx.doi.org/10.1016/j.trim.2011.10.001
   PubMedGoogle Scholar
• Vlad G, Suciu-Foca N. Induction of antigen-specific human T suppressor cells by membrane and soluble ILT3. Exp Mol Pathol 2012; PMID:23018130
   PubMedGoogle Scholar
• Vlad G, Cortesini R, Suciu-Foca N. CD8+ T suppressor cells and the ILT3 master switch. Hum Immunol 2008; 69:681-6; PMID:18817834; http://dx.doi.org/10.1016/j.humimm.2008.08.286
   PubMed Web of Science ®Google Scholar
• Waschbisch A, Sanderson N, Krumbholz M, Vlad G, Theil D, Schwab S, Mäurer M, Derfuss T. Interferon Beta and vitamin d synergize to induce immunoregulatory receptors on peripheral blood monocytes of multiple sclerosis patients. PLoS One 2014; 9:e115488; PMID:25551576; http://dx.doi.org/10.1371/journal.pone.0115488
   PubMed Web of Science ®Google Scholar
• Cella M, Dohring C, Samaridis J, Dessing M, Brockhaus M, Lanzavecchia A, Colonna M. A novel inhibitory receptor (ILT3) expressed on monocytes, macrophages, and dendritic cells involved in antigen processing. J Exp Med 1997; 185:1743-51; PMID:9151699; http://dx.doi.org/10.1084/jem.185.10.1743
   PubMed Web of Science ®Google Scholar
• Zhang Y, Lu N, Xue Y, Zhang M, Li Y, Si Y, Bian X, Jia Y, Wang Y. Expression of immunoglobulin-like transcript (ILT)2 and ILT3 in human gastric cancer and its clinical significance. Mol Med Rep 2012; 5:910-6; PMID:22246571
   PubMed Web of Science ®Google Scholar
• Dobrowolska H, Gill KZ, Serban G, Ivan E, Li Q, Qiao P, Suciu-Foca N, Savage D, Alobeid B, Bhagat G, et al. Expression of immune inhibitory receptor ILT3 in acute myeloid leukemia with monocytic differentiation. Cytometry B Clin Cytom 2013; 84:21-9; PMID:23027709; http://dx.doi.org/10.1002/cyto.b.21050
   PubMed Web of Science ®Google Scholar
• Jensen MA, Patterson KC, Kumar AA, Kumabe M, Franek BS, Niewold TB. Functional genetic polymorphisms in ILT3 are associated with decreased surface expression on dendritic cells and increased serum cytokines in lupus patients. Ann Rheum Dis 2013; 72:596-601; PMID:22904259; http://dx.doi.org/10.1136/annrheumdis-2012-202024
   PubMedGoogle Scholar